- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic and molecular epidemiology of adult diffuse glioma
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 15, Issue 7, Pages 405-417
Publisher
Springer Science and Business Media LLC
Online
2019-06-22
DOI
10.1038/s41582-019-0220-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using germline variants to estimate glioma and subtype risks
- (2019) Jeanette E Eckel-Passow et al. NEURO-ONCOLOGY
- Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction
- (2019) Sheila Alcantara Llaguno et al. NATURE NEUROSCIENCE
- Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci
- (2018) Karim Labreche et al. ACTA NEUROPATHOLOGICA
- cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant
- (2018) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Novel, improved grading system(s) for IDH-mutant astrocytic gliomas
- (2018) Mitsuaki Shirahata et al. ACTA NEUROPATHOLOGICA
- cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC)
- (2018) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Impact of atopy on risk of glioma: a Mendelian randomisation study
- (2018) Linden Disney-Hogg et al. BMC Medicine
- Occupational exposure to high-frequency electromagnetic fields and brain tumor risk in the INTEROCC study: An individualized assessment approach
- (2018) Javier Vila et al. ENVIRONMENT INTERNATIONAL
- DNA methylation-based classification of central nervous system tumours
- (2018) David Capper et al. NATURE
- Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
- (2018) Quinn T. Ostrom et al. Scientific Reports
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
- (2018) Quinn T. Ostrom et al. JAMA Oncology
- Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide
- (2018) Erica H. Bell et al. JAMA Oncology
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
- (2018) Daniel J. Brat et al. ACTA NEUROPATHOLOGICA
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Human glioblastoma arises from subventricular zone cells with low-level driver mutations
- (2018) Joo Ho Lee et al. NATURE
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide. A Pooled Analysis of Four Clinical Trials.
- (2018) Monika E Hegi et al. CLINICAL CANCER RESEARCH
- The molecular landscape of glioma in patients with Neurofibromatosis 1
- (2018) Fulvio D’Angelo et al. NATURE MEDICINE
- Integrated molecular characterization of IDH -mutant glioblastomas
- (2018) A. Korshunov et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Neutrophil–lymphocyte ratio dynamics during concurrent chemo-radiotherapy for glioblastoma is an independent predictor for overall survival
- (2017) Matthew Mason et al. JOURNAL OF NEURO-ONCOLOGY
- Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
- (2017) Beatrice S Melin et al. NATURE GENETICS
- Prognostic relevance of genetic alterations in diffuse lower-grade gliomas
- (2017) Kosuke Aoki et al. NEURO-ONCOLOGY
- Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas
- (2017) Josie Hayes et al. NEURO-ONCOLOGY
- Global incidence of malignant brain and other central nervous system tumors by histology, 2003–2007
- (2017) Rebecca Leece et al. NEURO-ONCOLOGY
- Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
- (2017) James R. Perry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunomethylomic approach to explore the blood neutrophil lymphocyte ratio (NLR) in glioma survival
- (2017) John K. Wiencke et al. Clinical Epigenetics
- Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
- (2017) et al. JAMA Oncology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Cell of origin of glioma: biological and clinical implications
- (2016) Sheila R Alcantara Llaguno et al. BRITISH JOURNAL OF CANCER
- Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study
- (2016) E. S. Amirian et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
- (2016) Dominik Sturm et al. CELL
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
- (2016) Michele Ceccarelli et al. CELL
- Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995–2012
- (2016) Paul Farah et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
- (2016) Brigitta G Baumert et al. LANCET ONCOLOGY
- Advances in the molecular genetics of gliomas — implications for classification and therapy
- (2016) Guido Reifenberger et al. Nature Reviews Clinical Oncology
- IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
- (2015) David E. Reuss et al. ACTA NEUROPATHOLOGICA
- Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
- (2015) Michael Weller et al. ACTA NEUROPATHOLOGICA
- A Meta-Analysis of Association Between Pesticides Exposure and Glioma Risk in Adults
- (2015) Hong-xing Li MM et al. JOURNAL OF CRANIOFACIAL SURGERY
- CDKN2ALoss Is Associated With Shortened Overall Survival in Lower-Grade (World Health Organization Grades II–III) Astrocytomas
- (2015) Gerald F. Reis et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue
- (2015) Paul R. Gielen et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Mutational landscape and clonal architecture in grade II and III gliomas
- (2015) Hiromichi Suzuki et al. NATURE GENETICS
- CD4+T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
- (2015) Daniel Dubinski et al. NEURO-ONCOLOGY
- Body mass index, physical activity, and risk of adult meningioma and glioma
- (2015) Tobias Niedermaier et al. NEUROLOGY
- Survival and low-grade glioma: the emergence of genetic information
- (2015) Elizabeth B. Claus et al. Neurosurgical Focus
- Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
- (2015) Jeanette E. Eckel-Passow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study identifies multiple susceptibility loci for glioma
- (2015) Ben Kinnersley et al. Nature Communications
- IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
- (2015) Heather E. Leeper et al. Oncotarget
- Targeted Sequencing in Chromosome 17q Linkage Region Identifies Familial Glioma Candidates in the Gliogene Consortium
- (2015) Ali Jalali et al. Scientific Reports
- A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase
- (2015) Anagha Killedar et al. PLoS Genetics
- Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
- (2014) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
- (2014) Felix Sahm et al. ACTA NEUROPATHOLOGICA
- A Prospective Study of Height and Body Mass Index in Childhood, Birth Weight, and Risk of Adult Glioma Over 40 Years of Follow-up
- (2014) C. M. Kitahara et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Changing incidence and improved survival of gliomas
- (2014) Vincent K.Y. Ho et al. EUROPEAN JOURNAL OF CANCER
- Menopausal hormone therapy and central nervous system tumor risk: Large UK prospective study and meta-analysis
- (2014) Victoria S. Benson et al. INTERNATIONAL JOURNAL OF CANCER
- Extent of Resection of Glioblastoma Revisited: Personalized Survival Modeling Facilitates More Accurate Survival Prediction and Supports a Maximum-Safe-Resection Approach to Surgery
- (2014) Nicholas F. Marko et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma
- (2014) Matthew N. Bainbridge et al. JNCI-Journal of the National Cancer Institute
- MGMT testing—the challenges for biomarker-based glioma treatment
- (2014) Wolfgang Wick et al. Nature Reviews Neurology
- The long-term risk of malignant astrocytic tumors after structural brain injury—a nationwide cohort study
- (2014) Tina Noergaard Munch et al. NEURO-ONCOLOGY
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reproductive factors in relation to risk of brain tumors in women: an updated meta-analysis of 27 independent studies
- (2014) Hailiang Zong et al. TUMOR BIOLOGY
- ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
- (2013) Benedikt Wiestler et al. ACTA NEUROPATHOLOGICA
- Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
- (2013) Volker Hovestadt et al. ACTA NEUROPATHOLOGICA
- Cigarette smoking, alcohol intake and risk of glioma in the NIH-AARP Diet and Health Study
- (2013) M Z Braganza et al. BRITISH JOURNAL OF CANCER
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- IDH1 and IDH2 Mutations in Gliomas
- (2013) Adam L. Cohen et al. Current Neurology and Neuroscience Reports
- Deciphering the 8q24.21 association for glioma
- (2013) Victor Enciso-Mora et al. HUMAN MOLECULAR GENETICS
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
- (2013) R. M. Bambury et al. JOURNAL OF NEURO-ONCOLOGY
- IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival
- (2013) S. Leu et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010
- (2013) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Time trends in glioblastoma multiforme survival: the role of temozolomide
- (2013) R. Dubrow et al. NEURO-ONCOLOGY
- Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
- (2013) W. Wick et al. NEUROLOGY
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Upper Midwest Health Study: Industry and occupation of glioma cases and controls
- (2012) Avima M. Ruder et al. AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
- Conditional probability of long-term survival in glioblastoma
- (2012) Derek R. Johnson et al. CANCER
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Mobile Phone Use and Incidence of Glioma in the Nordic Countries 1979–2008
- (2012) Isabelle Deltour et al. EPIDEMIOLOGY
- Epigenetic biomarkers of T-cells in human glioma
- (2012) John K. Wiencke et al. Epigenetics
- Epidemiology of glial and non-glial brain tumours in Europe
- (2012) Emanuele Crocetti et al. EUROPEAN JOURNAL OF CANCER
- Comparison of a Strategy Favoring Early Surgical Resection vs a Strategy Favoring Watchful Waiting in Low-Grade Gliomas
- (2012) Asgeir S. Jakola et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association between Traumatic Brain Injury and the Subsequent Risk of Brain Cancer
- (2012) Yi-Hua Chen et al. JOURNAL OF NEUROTRAUMA
- Association Between Prediagnostic IgE Levels and Risk of Glioma
- (2012) J. Schwartzbaum et al. JNCI-Journal of the National Cancer Institute
- Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study
- (2012) Mark S Pearce et al. LANCET
- Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
- (2012) Annika Malmström et al. LANCET ONCOLOGY
- Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
- (2012) Wolfgang Wick et al. LANCET ONCOLOGY
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation
- (2012) Robert B Jenkins et al. NATURE GENETICS
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- Leveraging Ethnic Group Incidence Variation to Investigate Genetic Susceptibility to Glioma: A Novel Candidate SNP Approach
- (2012) Daniel I. Jacobs et al. Frontiers in Genetics
- Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
- (2011) Amy S. Darefsky et al. CANCER
- Genome-Wide High-Density SNP Linkage Search for Glioma Susceptibility Loci: Results from the Gliogene Consortium
- (2011) S. Shete et al. CANCER RESEARCH
- Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
- (2011) Stuart A. Grossman et al. CLINICAL CANCER RESEARCH
- Chromosome 7p11.2 (EGFR) variation influences glioma risk
- (2011) Marc Sanson et al. HUMAN MOLECULAR GENETICS
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- An extent of resection threshold for newly diagnosed glioblastomas
- (2011) Nader Sanai et al. JOURNAL OF NEUROSURGERY
- Inherited predisposition to glioma
- (2011) A. P. Kyritsis et al. NEURO-ONCOLOGY
- Conditional Survival of All Primary Brain Tumor Patients by Age, Behavior, and Histology
- (2011) Kimberly R. Porter et al. NEUROEPIDEMIOLOGY
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
- (2010) Martin J. van den Bent ACTA NEUROPATHOLOGICA
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Survey of familial glioma and role of germline p16 INK4A /p14 ARF and p53 mutation
- (2010) Lindsay B. Robertson et al. Familial Cancer
- Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study
- (2010) Geoffrey C. Kabat et al. INTERNATIONAL JOURNAL OF CANCER
- DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
- (2010) Brock C. Christensen et al. JNCI-Journal of the National Cancer Institute
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide era
- (2009) Joseph L. Wiemels et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway
- (2009) Kari Hemminki et al. LANCET ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
- (2009) Margaret Wrensch et al. NATURE GENETICS
- Descriptive Epidemiology of Cerebral Gliomas in Northwest Greece and Study of Potential Predisposing Factors, 2005–2007
- (2009) K. Gousias et al. NEUROEPIDEMIOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analysis of the IDH1 codon 132 mutation in brain tumors
- (2008) Jörg Balss et al. ACTA NEUROPATHOLOGICA
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Age–incidence patterns of primary CNS tumors in children, adolescents, and adults in England
- (2008) Ramandeep S. Arora et al. NEURO-ONCOLOGY
- Functional Outcome after Language Mapping for Glioma Resection
- (2008) Nader Sanai et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search